Last reviewed · How we verify

NCT04982562: SPIN

Interest of the 7 Tesla MRI in the Diagnosis of Post-concussion Syndromes Among Patients With Mild Traumatic Brain Injury

Status unknown NA Last updated 11 January 2024
What this trial tests

NA trial testing 7T MRI in Post-Concussion Syndrome in 100 participants. Status unknown.

Timeline
26 June 2021
Primary endpoint
26 June 2024
26 June 2024

Quick facts

Lead sponsorPoitiers University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment100
Start date26 June 2021
Primary completion26 June 2024
Estimated completion26 June 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Poitiers University Hospital

Who can join

Adults 20 to 72, any sex, with Post-Concussion Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We aimed to conduct a prospective longitudinal interventionnal monocentric study to assess the ability of seven tesla MRI to detect diffuses axonal lesions in patients presenting a post concussional syndrom (PCS) at seven days about a mild traumatic brain injury (MTBI). Our first objective was to evaluate the diagnostic performance of seven tesla MRI runned at seven days after MTBI among patients presenting a PCS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of 7T MRI

Trials testing the same drug.

Other recruiting trials for Post-Concussion Syndrome

Currently open trials in the same condition.

Other Poitiers University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04982562.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing